bailon, l., Molto, J., Cadiñanos, J., Lopez Bernaldo de Quirós, J. C., De Los Santos Gil, I., Curran, A., & Suanzes, P. (2025). Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: A randomized, placebo-controlled phase 2a trial.
Citación estilo Chicagobailon, lucia, Jose Molto, Julen Cadiñanos, Juan Carlos Lopez Bernaldo de Quirós, Ignacio De Los Santos Gil, Adrian Curran, y Paula Suanzes. Safety, Immunogenicity and Effect On Viral Rebound of HTI Vaccines Combined With a TLR7 Agonist in Early-treated HIV-1 Infection: A Randomized, Placebo-controlled Phase 2a Trial. 2025.
Cita MLAbailon, lucia, et al. Safety, Immunogenicity and Effect On Viral Rebound of HTI Vaccines Combined With a TLR7 Agonist in Early-treated HIV-1 Infection: A Randomized, Placebo-controlled Phase 2a Trial. 2025.